Extreme heat prompts doctors to use body bags as cooling devices for heat stroke; a study of the effect of donanemab on the early stages of Alzheimer disease looks promising; UnitedHealth Group is seeing an influx of people seeking mental health care services, causing accessibility issues because of the provider shortage.
Extreme heat is now a public health emergency, at least according to emergency department doctors in Phoenix, who have created protocols to treat victims of heat stroke with immersive cooling in a body bag filled with ice zipped to shoulder level, according to STAT News. The bags provide an ideal way to treat these patients because they are waterproof, cool the person twice as fast as traditional methods, contain the cooling person and melting ice, and can allow room for intravenous tubing, temperature probes, and intubation if needed. Since the 1960s, heat waves have become more intense, frequent, and prolonged, putting those vulnerable to heat-related illness in danger.
Phase 3 trial results indicate that the earlier the treatment with the experimental drug donanemab, the better for patients with Alzheimer disease, especially when symptoms and brain pathology are mildest, giving a better chance of slowing cognitive decline, reported The New York Times. The study illustrated that donanemab, manufactured by Eli Lilly, can moderately slow the progression of memory and thinking issues in the early stages of Alzheimer disease, with the most progress seen in patients in the early stages when they possessed less of the tau protein that creates tangles in the brain.
UnitedHealth Group reported that the percentage of enrollees getting psychological care was up by double digits since last year, with the shift believed to symbolize long-term change, according to The Wall Street Journal. The payer suggested that people feel more comfortable looking for help for behavioral health issues, but it observes a continuing shortage of mental health care providers that is creating accessibility issues. The increased use of behavioral health care was 1 motivator of higher health care costs highlighted by the company during a call talking about its second-quarter financial results.
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation
August 25th 2025Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after starting efgartigimod.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen